Intravenous delivery of oncolytic reovirus to brain tumor patients immunologically primes for subsequent checkpoint blockade.
向脑肿瘤患者静脉注射溶瘤病毒可使患者对后续的免疫检查点阻断疗法产生免疫启动作用
期刊:Science Translational Medicine
影响因子:14.6
doi:10.1126/scitranslmed.aam7577
Samson Adel, Scott Karen J, Taggart David, West Emma J, Wilson Erica, Nuovo Gerard J, Thomson Simon, Corns Robert, Mathew Ryan K, Fuller Martin J, Kottke Timothy J, Thompson Jill M, Ilett Elizabeth J, Cockle Julia V, van Hille Philip, Sivakumar Gnanamurthy, Polson Euan S, Turnbull Samantha J, Appleton Elizabeth S, Migneco Gemma, Rose Ailsa S, Coffey Matthew C, Beirne Deborah A, Collinson Fiona J, Ralph Christy, Alan Anthoney D, Twelves Christopher J, Furness Andrew J, Quezada Sergio A, Wurdak Heiko, Errington-Mais Fiona, Pandha Hardev, Harrington Kevin J, Selby Peter J, Vile Richard G, Griffin Stephen D, Stead Lucy F, Short Susan C, Melcher Alan A